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Introduction 
The problem of homograft rejec-
tion in man remains unsolved. Any 
organ transplanted from one indi-
vidual to another (except in the 
case of identical twins) will be re-
jected, unless the rejection process 
can be abated by some method. Un-
fortunately, homograft rejection 
still occurs all too frequently, and 
the toxicity of the drugs used pre-
sents problems. However, in other 
animal systems the rejection pro-
cess is directly related to the degree 
of antigenic difference between the 
donor and the recipient. Recently, 
various transplantation centers have 
tried to achieve antigenic similarity 
between the donor and the recipient 
as a means of improving the homo-
graft survival rate. In order to do 
this, the antigens of the potential 
donors and the recipient are meas-
ured in vitro. This is called tissue 
typing, or histocompatibility match-
ing. 
Humans have been shown to de-
velop antibodies against donor cells 
following multiple blood transfu-
sions, multiple pregnancies, organ 
homografting and deliberate immu-
nization using repeated injections 
of leukocytes or platelets. Such an-
tibodies are cross-reactive in vary-
ing percentages of the random 
population. A panel of such anti-
bodies or antisera can be tested 
against any individual's cells to de-
termine his antigenicity. This can 
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then be compared with the results 
of typing from other individuals 
prior to transplantation. 
Antibodies have been identified 
against an antigen system known as 
HL-A (Table 1) . Tissue typing 
studies performed in families have 
shown that this system is the result 
of antigenic determinants present 
on the same pair of chromosomes 
at several subloci. However, the 
exact interrelationship of these de-
terminants is not fully known. The 
use of the HL-A terminology for 
the antigens has simplified the ex-
change of information in this field. 
The original terminology of vari-
ous investigators for these antigens 
is also shown in Table 1. 
Methods 
The methods most commonly 
employed in tissue typing are: 1) 
lymphocytotoxicity; 2) leukoagglu-
tination; 3) platelet complement 
fixation; 4) mixed cell agglutina-
tion; 5) immune adherence; and 
6) mixed lymphocyte culture. The 
lymphocytotoxicity test is the most 
commonly employed test and re-
quires viable lymphocytes, a for-
eign complement source (generally, 
rabbit complement), and a battery 
of antisera. Cell death occurs if an 
antigen-antibody-complement reac-
tion takes place. The most common 
method of detecting cell death is a 
dye exclusion method. Whereas 
dead cells imbibe the surrounding 
fluid, including the dye, and ap-
pear larger and darker on the in-
verted phase microscope, living 
cells with intact cell membranes 
exclude the surrounding fluid and 
dye. Terasaki and co-workers have 
developed one form of this tech-
nique (Terasaki, Vredevoe and 
Mickey, 1967; Mittal et al., 1968). 
An alternate method of determin-
ing cell death is to preincubate the 
lymphocytes with 5 1Cr and then 
determine the release of this isotope 
as an indication of cell death (Ro-
gentine and Plocinik, 1967). 
Reproducibility of these tests is 
good, with about a 3% error. How-
ever, the tests cannot be done with 
cells other than lymphocytes, e.g. , 
kidney cells. An assumption is 
made that lymphocytes react simi-
larly to cells from transplantable 
organs, i.e., kidney, heart. How-
ever, this may not be the case. The 
need for viable lymphocytes to per-
form the test precludes the later 
testing of cadaver donors unless the 
lymphocytes are specially freeze-
preserved or maintained in tissue 
culture. An outline of the lympho-
cytotoxicity test employed at the 
Medical College of Virginia is 
shown in Table 2. 
Leukoagglutination is also a 
commonly employed method of 
tissue typing. In this method leu-
kocytes (whole "huffy coat") are 
reacted with the panel of antisera 
without any complement (Zmijewski 
et al., 1967). An antigen-antibody 
reaction leads to agglutination of 
the white blood cells. There are a 
number of antibodies which are 
more reactive in the leukoagglutina-
tion test than in the lymphocyto-
toxicity test, as well as several anti-
bodies which are demonstrable only 
by leukoagglutination. However, 
these later antibodies presumably 
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TABLE 1 
Nomenclature of HL-A System Terminology of 3 Investigators 
Dausset van Rood 
HL-Al 11 LAl 
HL-A2 1 (MAC) SA 
HL-A3 12 LA3 
HL-A5 5 DAS 
HL-A7 10 7C 
HL-AS 8 7D 
4A 
4B 
4C 
TABLE 2 
Outline of Lymphocytotoxicity Test 
1 . Prepare pure suspension of lymphocytes 
a. Freshly drawn specimen 
b . Mailed specimen 
2. Add lymphocytes to previously prepared trays of 
110 antisera + recipient's sera 
3. Add pooled rabbit complement 
4. Add eosin and formalin 
5. Allow cells to resettle and prepare trays for readings 
6. Read microtest trays on inverted phase microscope 
7. Evaluate typing 
MIXED AGGLUTINATION 
Rh (D)• RBC 
Payne 
LAI 
LA2 
LA3 
4D 
7D 
45 min 
60 min 
60-120 min 
30 min 
15 min 
15 min 
4-5 hr 
·w~ ~ [><ANTI l~;G~NTIBOD' 
GOAT ANTI~ -.f \~ id-- ~SERUM AB 
HUMAN lgG .-:;;__,_._ ~ 
KIDNEY CELLS 
Fig. 1-The mixed cell agglutination test. See text. 
are not recognizing important trans-
plant antigens. 
The platelet complement fixation 
test requires platelets, complement, 
and a battery of antisera (Shulman 
et al., 1964). This test is no longer 
widely employed. Dausset (1969) 
recently described new antigen-
antibody reactions-related to the 
HL-A system-which occurred with 
this test but were not demonstrable 
in the lymphocytotoxic or leukoag-
glutination tests. 
All three of these tests require a 
large panel of antisera. Whereas 
erythrocyte typing requires only a 
single anti-A serum and a single 
anti-B serum. This is because the 
transplantation antigens as well as 
the antisera employed for detecting 
these antigens are poorly defined. 
The three other techniques of 
tissue typing are not widely em-
ployed at present but may have 
wider application in the future. 
Mixed cell agglutination requires 
that the target cells be grown in 
tissue culture monolayers (Milgrom 
et al., 1966). However, any cell 
line capable of being grown in tis-
sue culture may be used . Attempts 
to employ this test with dispersed, 
fresh cells, cryostat sections, or 
fresh tissue slices have been unsuc-
cessful. This test requires a special 
indicator cell system consisting of 
human erythocytes precoated with 
an antibody directed against human 
erythrocytes and an anti-human an-
tibody capable of reacting with both 
the first antibody and the test anti-
sera. At the Medical College of 
Virginia this indicator system con-
sists of Rh+ erythrocytes precoated 
with anti-Rh antibody and a goat 
anti-human antibody. The test anti-
serum is layered over the mono-
layer of target cells, followed by 
thorough washing and the addition 
of the coated indicator cell system. 
Agglutination of the indicator cell 
system indicates that the test anti-
serum has reacted with the target 
cell (Fig. 1) . 
The immune adherence test re-
quires a cell suspension, potent 
complement source, and human 
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erythrocytes (Nelson, 1956). It 
can be performed with various 
types of cells-dead or alive. If an 
antigen-antibody-complement reac-
tion takes place, the erythrocyte in-
dicator cells will adhere to the tar-
get cell. The immune adherence 
and mixed cell agglutination tests 
are much more sensitive than the 
previously described tests. The 
mixed lymphocyte culture technique 
has been described in full by Bach 
(1966). 
In the immune adherence test a 
comparison of reactivity of lympho-
cytes and kidney cells from one 
individual against the same anti-
sera revealed these results in the 
five individuals studied: 37 nega-
tive reactions against lymphocytes 
and kidney cells, 15 positive re-
actions against lymphocytes and 
kidney cells, 29 reactions in which 
the antisera reacted positively with 
kidney cells and negatively with 
lymphocytes, and four instances in 
which the reverse relationship 
existed. This is presumptive evi-
dence for an antigenic difference 
between kidney cells and lympho-
cytes. Whether or not it is a quali-
tative or quantitative difference is 
not shown by these data. At any 
rate, the data are against the as-
sumption that, by typing leuko-
cytes, one can determine the full 
antigenicity of an organ to be trans-
planted. 
A similar discrepancy has been 
demonstrated by testing lympho-
cytes and kidney cells from the 
same individual-through use of 
the lymphocytotoxicity and mixed 
cell agglutination tests, respectively. 
In retesting an individual's cells 
against an antiserum in which the 
lymphocytotoxicity reaction was 
negative and the mixed cell agglu-
tination reaction positive, the dif-
ference in reactivity appeared to be 
quantitative, as prior absorption 
with the individual's leukocytes re-
moved the reactivity against kidney 
cells, despite there originally being 
no reactivity demonstrable by lym-
phocytotoxicity testing. 
Since the antigenic determinants 
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TABLE 3 
Examples of Lymphocyte Typing Results " A" Match 
Example 1 
HL-Al HL-A2 HL-A3 HL-A7 HL-AS 4A 4B 4C 
Donoc + + + + + 
Recipient + + + + + 
4 of 100 sera "killed" donor's but not recipient's cells 
Example 2 
HL-AI HL-A2 HL-A3 HL-A7 HL-AS 4A 4B 4C 
Donor + 
Recipient + + + + + 
1 of 100 sera "killed" donor's but not recipient's cells. All of above differences 
in antigenic groups are in the "minor direction." 
for the HL-A system occur on the 
same pair of chromosomes, there 
is a 25 % chance that a sibling will 
be identical with any other sibling 
for the HL-A system. By tissue typ-
ing a family, it can be determined 
which individuals share 0, 1, or 
both chromosomes. Amos et al. 
( 1969) have shown that skin grafts 
between nonimmunosuppressed sib-
lings known to be identical for 
the HL-A system have a mean sur-
vival of about 25 days. The failure 
of permanent graft take might in-
dicate that there are other antigenic 
systems present on other chromo-
somes which are not yet defined. 
Detailed absorption studies have 
been done in our laboratory to 
demonstrate the presence of HL-A 
antigens in various human tissues, 
i.e., kidney, liver, heart, blood ves-
sels, lung, skin, pancreas, ureter 
and fat. Kidney and liver tissue 
were found to contain all eight of 
the well recognized HL-A antigens, 
whereas fat had no HL-A antigens. 
The other tissues studied were not 
tested for all eight antigen groups 
but did contain every antigen for 
which tests were run (Rolley, Wil-
liams and Hume, 1968). These 
studies were sufficiently controlled 
to exclude the possibilities of non-
specific loss of antibody activity 
through surface absorption phenom-
ena or by anti-complementary fac-
tors. The studies indicated that the 
HL-A system is widely distributed 
in human organs, but this does not 
preclude the possibility that tissues 
possess important histocompatibil-
ity antigens not detectable on leuko-
cytes. The possibility of such tis-
sue transplantation antigens being 
poorly expressed on leukocytes has 
been shown in the ABO erythro-
cyte system. 
Histocompatibility Matching 
Of the six tissue typing tech-
niques discussed above, only mixed 
lymphocyte culture involves direct 
interaction between donor and re-
cipient cells. The other five tests all 
use a comparison of results against 
a panel of antisera. A histocompat-
ibility match may be reported on 
an A, B, C, or D scale. The terms 
A and B are comparable to the 
terms matched or compatible; the 
terms C and D are comparable to 
the terms mismatched or incom-
patible. Table 3 shows two exam-
ples of an A match. In the upper 
example of that table, the antigenic-
ity of the donor and the recipient 
for these eight antigens is the same. 
However, a great deal of attention 
is also given to individual serum 
reactions, since not all sera have 
been classified for one of these par-
ticular antigen groups. In this ex-
ample 4% of the sera reacted 
with antigens of the donor but not 
of the recipient. Theoretically, the 
recipient is capable of reacting to 
such foreign antigens. 
TABLE 4 
Examples of Lymphocyte Typing Results 
HL-Al HL-A2 
Donor + + 
Recipient + + 
TISSUE TYPING 
In the second example of an A 
match in Table 3, the recipient bas 
more antigen groups than the 
donor. At our present level of 
knowledge, this is assumed not to 
affect graft survival and therefore, 
the example is not considered a 
mismatch; but rather an A match. 
Table 4 shows an example of a 
B match in which no recognized 
antigen groups are present on donor 
cells but absent on recipient cells. 
However, more than 5 % of the 
individual sera detected antigens on 
donor but not recipient cells; hence, 
this match is rated B rather than A. 
Table 4 also shows an example 
of a C match in which a well rec-
ognized antigen group is present on 
donor cells but absent on recipient 
cells. A D match (Table 4) indi-
cates a donor-to-recipient mismatch 
of two antigen groups. 
Preformed Antibodies 
Tissue typing tests determine 
neither the presence of preformed 
antibodies against donor antigens, 
nor the presence of organ-specific 
"B" Match 
auto-antibodies, such as the anti-
glomerular basement membrane 
antibodies. To look for preformed 
antibodies against histocompatibil-
ity antigens, it is necessary to per-
form a cross match test using the 
recipient's serum and donor's cells. 
This can be done by any one of 
the five tissue typing methods dis-
cussed in this paper. If preformed 
antibodies are found and a trans-
plant performed, there is a great 
probability that the transplant will 
be rejected very quickly. A dis-
cussion of the detection of auto-
antibodies is beyond the scope of 
this paper. 
At present, bistocompatibility 
matching is an inexact science, and 
there are undoubtedly many histo-
compatibility antigens either poorly 
defined or undefined. With further 
definition of such antigens, im-
provement can be expected in the 
correlation of tissue typing with 
homograft function and survival. 
Further work also needs to be done 
to determine which method of tis-
sue typing is best. 
HL-A3 HL-A7 HL-AS 4A 4B 4C 
+ 
+ 
12 of 100 sera "killed" donor's but not recipient's sera. 
"C" Match 
----
I HL-A l HL-A2 HL-A3 HL-A7 HL-A8 4A 4B 4C 
Donor + + + 
Recipient l + + + + 
1 group mismatch in "major direction." 
"D" Match 
HL-Al ff HL-A3 ITJ HL-AS 4A 4B 4C Donor + + + Recipient + + + 
2 group mismatches in "major direction." 
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